Cardiovascular disease and chimeric antigen receptor cellular therapy

Chimeric antigen receptor T-cell (CAR T) therapy is a revolutionary personalized therapy that has significantly impacted the treatment of patients with hematologic malignancies refractory to other therapies. Cytokine release syndrome (CRS) is a major side effect of CAR T therapy that can occur in 70...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Anjali, Stewart, Andrew, Eljalby, Mahmoud, Ramakrishnan, Praveen, Anderson, Larry D., Awan, Farrukh T., Chandra, Alvin, Vallabhaneni, Srilakshmi, Zhang, Kathleen, Zaha, Vlad G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538377/
https://www.ncbi.nlm.nih.gov/pubmed/36211558
http://dx.doi.org/10.3389/fcvm.2022.932347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538377/
https://www.ncbi.nlm.nih.gov/pubmed/36211558
http://dx.doi.org/10.3389/fcvm.2022.932347

Ejemplares similares